New Program Will Provide Real-Time Coaching to Support the Prevention and Management of Atherosclerotic Cardiovascular Disease and Coronary Artery Disease
MOUNTAIN VIEW, Calif., March 16, 2022 /PRNewswire/ — Lark Health today announced the development of a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease (ASCVD) and coronary artery disease (CAD) in collaboration with Roche Diagnostics. The program, named Lark Heart Health, is an AI-driven virtual care solution that provides personalized health coaching anytime, anywhere. The new Heart Health program is planned to launch later this year.
Cardiovascular disease (CVD) is the leading cause of death globally, and nearly half of all adults in the U.S. have some form of CVD. It’s also one of the most expensive chronic conditions, with heart disease and stroke costing the U.S. healthcare system roughly $214 billion annually. Yet, provider shortages and siloed care teams leave patients with limited care options, gaps in care, and insufficient education and empowerment to self-manage their heart health. Additionally, high treatment costs and resource constraints often limit care to those with the highest acuity conditions.
Built using a Cognitive Behavioral Therapy (CBT) framework and designed in accordance with guidelines from the American Heart Association (AHA), Lark Heart Health will provide a cost-effective, scalable solution for continuous, person-centric remote heart health coaching intended to help users improve their healthy lifestyle behaviors, reduce stress levels, and ultimately decrease risk factors for heart disease. Through an evidence-based educational curriculum and real-time personalized coaching, Lark will provide users with the tools they need to make meaningful lifestyle changes that can help them better prevent and manage ASCVD and CAD.
Earlier this year, Lark announced it had joined the AHA’s Network at American Heart Association Center of Health Technology & Innovation, which is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
“Lark Heart Health will help those at high risk prevent and actively manage cardiovascular disease through personalized digital coaching,” said Julia Hu, co-founder and CEO of Lark. “By leveraging our AI technology, we can deliver meaningful and engaging care at an unprecedented scale, and this collaboration with Roche Diagnostics will support the expansion of our proven tech platform into one of the costliest chronic disease markets.”
For more information about Lark and its chronic disease prevention and management A.I. platform, please visit www.lark.com.
About Lark Health
Lark is a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI. To date, Lark has provided nearly 2 million people with unlimited, 24/7 personalized care delivered through an easy-to-use, text message-like interface that integrates remote patient monitoring tools and is built on a cognitive behavioral therapy framework. Lark’s platform seamlessly integrates with health plans’ and employers’ existing healthcare infrastructure to help them scale their chronic disease prevention and management programs, boost engagement, and improve health outcomes. Lark currently works with many of the largest health plans and across four programs: Prevention, Diabetes Prevention, Diabetes Care, and Hypertension Care. Lark’s Diabetes Prevention Program, which is the fastest growing and lowest cost DPP, has received the highest level of clinical recognition—Full Recognition—from the Centers for Disease Control and Prevention. The company has received numerous accolades, including having been named as one of CB Insights Digital Health 150 (2019), a finalist for the UCSF Digital Health Awards (2020), one of Fast Company’s Most Innovative Companies (multiple years), and one of Fierce Healthcare’s Fierce 15 (2020). To learn more, visit www.lark.com.
Press Contact:
Dori Zweig
lark@crosscutstrategies.com
SOURCE Lark Health
